- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04012723
Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients at Risk for Acute Compartment Syndrome
Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients With an Upper or Lower Extremity Fracture at Risk for Acute Compartment Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Abdelkrim Temzi
- Phone Number: 5145616809
- Email: abdel.temzi@my01.io
Study Contact Backup
- Name: Kelly Trask
- Phone Number: 902-473-3161
- Email: kelly.trask@nshealth.ca
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- Foothills Medical Center
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 1V7
- Halifax Infirmary
-
-
Ontario
-
London, Ontario, Canada, N6A 5W9
- London Health Sciences Centre
-
Ottawa, Ontario, Canada, K1Y 4E9
- Ottawa Civic Hospital
-
Toronto, Ontario, Canada, M5B 1W8
- St. Michael's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults age 16-65.
- Fracture of the tibia, foot, forearm, femur, or humerus that is felt by the surgeon to have a reasonable indication that elevated intracompartmental pressure could occur in the patient.
- Planned admission to hospital (to enable monitoring of compartment pressures)
- Provision of informed consent to participate.
Exclusion Criteria:
- Frankly contaminated or infected wounds or fractures.
- Clinical suspicion of acute compartment syndrome requiring urgent fasciotomy at time of presentation to study center.
- Current or pre-existing neuropathy in the study limb.
- Pregnant women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MY01 Device
Device: MY01 Device Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure |
The MY01 Continuous Compartmental Pressure Monitor is intended for real-time and continuous measurement of compartmental pressures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical ease with which the MY01 device is able to be inserted into a compartment.
Time Frame: 24-48 hours following device insertion.
|
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you that the sensor is in the correction position?" [1 = uncertain] - [5 = very certain]. The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 5 should be considered a positive scenario, whereas a record of 1 should indicate a negative scenario. |
24-48 hours following device insertion.
|
Ability to monitor in real time the continuous pressure readout from the compartment in remote locations via smartphone.
Time Frame: 24-48 hours following device insertion.
|
At insertion of device the physician will complete a feedback questionnaire on the device, the participant will be assessed for adverse events, and routine assessment will be performed.
|
24-48 hours following device insertion.
|
The change in intracompartmental pressure.
Time Frame: 24-48 hours following device insertion.
|
Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.
|
24-48 hours following device insertion.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events associated with the use of the device.
Time Frame: 24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment.
|
The patient will be monitored for adverse events during treatment, and will be reassessed during the final follow-up of the participant at the first return visit to the fracture clinic.
An adverse event constitutes "Any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal lab findings) in participants, users or other persons, whether or not related to the investigational device."
|
24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment.
|
Pain at insertion site.
Time Frame: 24-48 hours following device insertion.
|
Participants will be asked to keep a diary while the device is in situ.
The diary will consist of a pain Visual Analog Score (VAS) to be completed each time their vitals are taken, with space to freely comment on the device.
VAS will be on a sliding scale where [0=no pain] and [10=pain as bad as it can be].
|
24-48 hours following device insertion.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ross Leighton, MD, Orthopaedic Surgeon, Nova Scotia Health Authority
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MY01-NS-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Compartment Syndrome Traumatic Lower Extremity
-
Oregon Health and Science UniversityActive, not recruitingCompartment Syndrome Traumatic Lower ExtremityUnited States
-
University of PortsmouthPortsmouth Hospitals NHS TrustNot yet recruitingCompartment Syndrome Nontraumatic Lower ExtremityUnited Kingdom
-
Brigham and Women's HospitalEnrolling by invitationLower Extremity Amputation | Trans-Tibial Amputation | Traumatic Lower Extremity Amputation | Agonist-Antagonist Myoneural InterfaceUnited States
-
US Department of Veterans AffairsMassachusetts Institute of TechnologyCompletedTraumatic Amputation of Lower ExtremityUnited States
-
VA Eastern Colorado Health Care SystemCompletedTraumatic Amputation of Lower ExtremityUnited States
-
Alicia KoontzCompletedTraumatic Amputation of Lower ExtremityUnited States
-
Miami VA Healthcare SystemCompletedTraumatic Amputation of Lower ExtremityUnited States
-
VA Eastern Colorado Health Care SystemUnited States Department of DefenseCompletedWounds and Injuries | Amputation, Traumatic | Traumatic Amputation of Lower ExtremityUnited States
-
University of Illinois at ChicagoNot yet recruitingTraumatic Amputation of Lower Extremity
-
Stryker OrthopaedicsCompletedTraumatic Amputation of Lower ExtremityUnited Kingdom
Clinical Trials on MY01 Continuous Compartmental Pressure Monitor
-
MY01 Inc.McGill University Health Centre/Research Institute of the McGill University... and other collaboratorsCompletedAcute Compartment SyndromeCanada
-
McGill University Health Centre/Research Institute...United States Department of Defense; Vanderbilt University Medical Center; Hennepin...RecruitingAcute Compartment SyndromeUnited States
-
Empirical Technologies CorporationUniversity of VirginiaCompletedBlood Pressure
-
Robert HanssUnknown
-
Mayo ClinicCompletedHypertension | DiabetesUnited States
-
Cairo UniversityCompletedObesity | Blood PressureEgypt
-
Hacettepe UniversityCompletedEndotracheal Tube | Sore Throat | Cuff PressureTurkey
-
Yale UniversityMedtronicWithdrawn
-
Denver Health and Hospital AuthorityEnrolling by invitationAvoidant Restrictive Food Intake Disorder | Anorexia Nervosa, Binge Eating/Purging Type | ARFID | Anorexia Nervosa Restricting TypeUnited States
-
University of VirginiaDexCom, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1United States